LEXARIA BIOSCIENCE CORP. Conversion of Stock, Shares Converted
LEXARIA BIOSCIENCE CORP. (LEXX) reported Conversion of Stock, Shares Converted of 264.38 thousand shares for the 12-month period ending 2025-08-31, per its 10-K filed 2025-11-28.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2025-11-28
- LEXARIA BIOSCIENCE CORP. conversion of stock, shares converted for the quarter ending 2024-08-31 was -110.88K shares, a 349.84% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. conversion of stock, shares converted for the quarter ending 2024-05-31 was 138.25K shares.
- LEXARIA BIOSCIENCE CORP. conversion of stock, shares converted for the quarter ending 2024-02-29 was 0.00 shares.
- LEXARIA BIOSCIENCE CORP. conversion of stock, shares converted for the quarter ending 2023-11-30 was 11.75K shares.
- LEXARIA BIOSCIENCE CORP. conversion of stock, shares converted for fiscal 2025 was 264.38K shares, a 575.86% increase from fiscal 2024.
- LEXARIA BIOSCIENCE CORP. conversion of stock, shares converted for fiscal 2024 was 39.12K shares, a 30.31% decline from fiscal 2023.
- LEXARIA BIOSCIENCE CORP. conversion of stock, shares converted for fiscal 2023 was 56.13K shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|
| 2025-08-31 | 264.38K shares 10-K · filed 2025-11-28 | |||
| 2024-08-31 | -110.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | 27.37K shares derived: sum of 2 quarters · filed 2024-11-26 | 27.37K shares derived: sum of 3 quarters · filed 2024-11-26 | 39.12K shares 10-K · filed 2024-11-26 |
| 2024-05-31 | 138.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | 138.25K shares derived: sum of 2 quarters · filed 2024-07-12 | 150.00K shares 10-Q · filed 2024-07-12 | 194.38K shares derived: sum of 4 quarters · filed 2024-07-12 |
| 2024-02-29 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | 11.75K shares 10-Q · filed 2024-04-09 | 56.13K shares derived: sum of 3 quarters · filed 2024-04-09 | 40.38K shares derived: sum of 4 quarters · filed 2024-04-09 |
| 2023-11-30 | 11.75K shares 10-Q · filed 2024-01-12 | 56.13K shares derived: sum of 2 quarters · filed 2024-01-12 | 40.38K shares derived: sum of 3 quarters · filed 2024-01-12 | |
| 2023-08-31 | 44.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | 28.63K shares derived: sum of 2 quarters · filed 2023-11-20 | 56.13K shares 10-K · filed 2023-11-20 | |
| 2023-05-31 | -15.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | 11.75K shares 10-Q · filed 2023-07-14 | ||
| 2023-02-28 | 27.50K shares 10-Q · filed 2023-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |